MedTrace Logo

Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin

NCT00217451 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2005-09-22

No results posted yet for this study

Summary

Some antibiotics are also effective against malaria parasites. Fosmidomycin is an antibiotic that has been shown to be effective against malaria, although it cannot achieve a total cure in all patients. A previous small study has shown that in combination with clindamycin, an commonly used antibiotic, it is highly effective and safe, in asymptomatic carriers of malaria parasites. The current study will evaluate the efficacy and safety of the combination given for three days in children with uncomplicated malaria in Gabon.

Conditions

Interventions

DRUG

Fosmidomycin-clindamycin

Sponsors & Collaborators

  • Albert Schweitzer Hospital

    lead OTHER

Principal Investigators

  • Steffen Borrmann, MD · Kenya Medical Research Institute, Centre for Geographic Medicine Research, Coast, kilifi, Kenya

  • Peter G. Kremsner, MD, FRCP · Albert Schweitzer Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Months
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Completion
2003-03-31

Countries

  • Gabon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00217451 on ClinicalTrials.gov